Libbe Englander

CEO and Founder, Pharm3r

Libbe founded Pharm3r in 2011 to apply programmatic approaches such as natural language processing and web scraping to help evaluate medical products and companies. Prior to Pharm3r she founded, ran and successfully sold a healthcare hedge fund. The fund utilized healthcare industry expertise to identify tail risk and drew on Libbe’s experience managing a competitive intelligence and healthcare company advisory firm. Libbe has a Ph.D. in Molecular Biology from The Rockefeller University and a B.S. in Biology from Yale University.